• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSL1600040 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Import Drug Application 2016-07-11 Bayer Healthcare LLC Certificate Issued 2018-07-27 view
JYSB2101169 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2021-11-25 Pfizer Europe Ma Eeig;Wyeth Farma SA view
JYSB1900243 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2019-09-05 Wyeth Farma SA;Pfizer Ltd Filed 2019-09-16 view
JYSB2101161 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2021-11-10 Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG view
JYSB1500133 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2015-05-19 Baxter AG;Baxter Bioscience Manufacturing Sarl Certificate Issued 2017-03-27 view
JYSB1800202 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2018-09-29 Wyeth Farma SA;Pfizer Ltd Certificate Issued 2019-06-04 view
CYSB2200011 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原10) Supplementary Application 2022-01-10 SinoCelltech Ltd view
JYSB1400239 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2014-12-09 Wyeth Farma SA;Wyeth Pharmaceuticals Inc Certificate Issued 2015-06-19 view
JYSB1800056 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2018-03-28 Baxter AG;Baxalta Manufacturing Sàrl Filed 2018-04-13 view
JYSB2400250 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-12-04 Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG view
JYSB2000558 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2020-11-04 Bayer Healthcare LLC Filed 2020-11-17 view
JYSB1600273 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2017-01-03 Wyeth Farma SA;Wyeth Pharmaceuticals Inc Certificate Issued 2017-04-10 view
JYSZ2200029 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2022-06-29 Pfizer Europe Ma Eeig;Wyeth Farma SA;Pfizer Investment Co Ltd view
JYSB2400051 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-03-07 Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG view
JXSL0900046 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Import Drug Application 2009-07-01 Bayer Healthcare LLC Certificate Issued 2011-01-19 view
JYSB2200143 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2022-08-08 Bayer Healthcare LLC view
JYSZ1600015 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2016-05-10 Baxter AG;Baxalta Manufacturing Sàrl Certificate Issued 2017-04-19 view
JYSB1900085 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2019-04-24 Wyeth Farma SA;Pfizer Ltd Certificate Issued 2019-10-30 view
JYSB2101028 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2021-05-12 Bayer Healthcare LLC view
JYSZ1800031 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2018-07-20 Bayer Healthcare LLC Certificate Issued 2019-06-03 view